Search

everythinglearnresearchcommunity

for

Search:↓

A new hydrogel with stem cells from human umbilical cords improves skin wound healing and reduces inflammation.

New alopecia treatments aim for better results and fewer side effects.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

UV-B light increases inflammation-related substances in acne-related skin cells.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Transplanting growing hair follicles into scars can help regenerate and improve scar tissue.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Cow milk sugars increase fat production and inflammation in skin oil cells.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Demodex mites can cause skin issues, especially in people with weak immune systems.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Monocytes might be linked to hair loss after COVID-19.